Full text
PDF











Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AGGELER P. M., WHITE S. G., GLENDENING M. B., PAGE E. W., LEAKE T. B., BATES G. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. Proc Soc Exp Biol Med. 1952 Apr;79(4):692–694. doi: 10.3181/00379727-79-19488. [DOI] [PubMed] [Google Scholar]
- BIGGS R., DOUGLAS A. S., MACFARLANE R. G., DACIE J. V., PITNEY W. R., MERSKEY Christmas disease: a condition previously mistaken for haemophilia. Br Med J. 1952 Dec 27;2(4799):1378–1382. doi: 10.1136/bmj.2.4799.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BIGGS R., DOUGLAS A. S. The thromboplastin generation test. J Clin Pathol. 1953 Feb;6(1):23–29. doi: 10.1136/jcp.6.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COLNEY C. L., RATNOFF O. D., ELLICOTT C. E., HARTMANN R. C. Studies on the initiation of blood coagulation. II. An anticoagulant inhibiting the activation of a plasma thromboplastic factor. J Clin Invest. 1950 Sep;29(9):1182–1188. doi: 10.1172/JCI102356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Christensen L. R. METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE. J Clin Invest. 1949 Jan;28(1):163–172. doi: 10.1172/JCI102045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conley C. L., Hartmann R. C., Morse W. I., 2nd THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN". J Clin Invest. 1949 Mar;28(2):340–352. doi: 10.1172/JCI102077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FIALA S., ROTH K. [Platelets and the thromboplastic system of blood coagulation]. Arch Int Physiol. 1953 Apr;61(2):205–231. doi: 10.3109/13813455309147710. [DOI] [PubMed] [Google Scholar]
- FLYNN J. E., COON R. W. Purification and isolation of certain intermediates formed prior to the activation of prothrombin. Am J Physiol. 1953 Nov;175(2):289–295. doi: 10.1152/ajplegacy.1953.175.2.289. [DOI] [PubMed] [Google Scholar]
- JOHNSON S. A., SMATHERS W. M., SCHNEIDER C. L. Platelets and their plasma cofactor activity in the activation of purified prothrombin. Am J Physiol. 1952 Sep;170(3):631–635. doi: 10.1152/ajplegacy.1952.170.3.631. [DOI] [PubMed] [Google Scholar]
- Lozner E. L., Taylor F. H., Macdonald H. THE EFFECT OF FOREIGN SURFACES ON BLOOD COAGULATION. J Clin Invest. 1942 Mar;21(2):241–245. doi: 10.1172/JCI101295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MANN F. D., HURN M. M. The complex mechanisms of the quick prothrombin test and the effect of dicumarol. Am J Clin Pathol. 1950 Mar;20(3):225–232. doi: 10.1093/ajcp/20.3.225. [DOI] [PubMed] [Google Scholar]
- MILSTONE J. H. Fractionation of plasma globulin for prothrombin, thrombokinase, and accessory thromboplastin. J Gen Physiol. 1951 Sep;35(1):67–87. doi: 10.1085/jgp.35.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
- Patek A. J., Stetson R. P. HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETS. J Clin Invest. 1936 Sep;15(5):531–542. doi: 10.1172/JCI100806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D. An accelerating property of plasma for the coagulation of fibrinogen by thrombin. J Clin Invest. 1954 Aug;33(8):1175–1182. doi: 10.1172/JCI102990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., COLOPY J. E., PRITCHARD J. A. The blood-clotting mechanism during normal parturition. J Lab Clin Med. 1954 Sep;44(3):408–415. [PubMed] [Google Scholar]
- RATNOFF O. D., CONLEY C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull Johns Hopkins Hosp. 1951 Sep;89(3):245–254. [PubMed] [Google Scholar]
- RATNOFF O. D., HARTMANN R. C., CONLEY C. L. Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation. J Exp Med. 1950 Feb;91(2):123–133. doi: 10.1084/jem.91.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSENTHAL R. L., DRESKIN O. H., ROSENTHAL N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953 Jan;82(1):171–174. doi: 10.3181/00379727-82-20057. [DOI] [PubMed] [Google Scholar]
- ROSENTHAL R. L. Properties of plasma thromboplastin antecedent (PTA) in relation to blood coagulation. J Lab Clin Med. 1955 Jan;45(1):123–129. [PubMed] [Google Scholar]
- SCHULMAN I., SMITH C. H. Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood. 1952 Aug;7(8):794–807. [PubMed] [Google Scholar]
- SPAET T. H., AGGELER P. M., KINSELL B. G. A possible fourth plasma thromboplastin component. J Clin Invest. 1954 Aug;33(8):1095–1102. doi: 10.1172/JCI102982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TOCANTINS L. M., CARROLL R. T., HOLBURN R. H. The clot accelerating effect of dilution on blood and plasma. Relation to the mechanism of coagulation of normal and hemophilic blood. Blood. 1951 Aug;6(8):720–739. [PubMed] [Google Scholar]
- TRAVIS B. L., FERGUSON J. H. Proteolytic enzymes and platelets in relation to blood coagulation. J Clin Invest. 1951 Jan;30(1):112–123. doi: 10.1172/JCI102411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VAN CREVELD S., PAULSSEN M. M., VONK R. Isolation and properties of the third clotting factor in blood-platelets. Lancet. 1952 Jan 5;1(6697):23–25. doi: 10.1016/s0140-6736(52)90992-6. [DOI] [PubMed] [Google Scholar]